Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1999 1
2000 2
2003 2
2005 1
2006 3
2007 6
2008 6
2009 12
2010 11
2011 6
2012 6
2013 10
2014 12
2015 8
2016 8
2017 12
2018 8
2019 13
2020 22
2021 16
2022 11
2023 17
2024 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

186 results

Results by year

Filters applied: . Clear all
Page 1
Sarcoidosis: a review for the internist.
Bargagli E, Prasse A. Bargagli E, et al. Among authors: prasse a. Intern Emerg Med. 2018 Apr;13(3):325-331. doi: 10.1007/s11739-017-1778-6. Epub 2018 Jan 3. Intern Emerg Med. 2018. PMID: 29299831 Review.
Sarcoidosis.
Valeyre D, Prasse A, Nunes H, Uzunhan Y, Brillet PY, Müller-Quernheim J. Valeyre D, et al. Among authors: prasse a. Lancet. 2014 Mar 29;383(9923):1155-67. doi: 10.1016/S0140-6736(13)60680-7. Epub 2013 Oct 1. Lancet. 2014. PMID: 24090799 Review.
European Respiratory Society statement on familial pulmonary fibrosis.
Borie R, Kannengiesser C, Antoniou K, Bonella F, Crestani B, Fabre A, Froidure A, Galvin L, Griese M, Grutters JC, Molina-Molina M, Poletti V, Prasse A, Renzoni E, van der Smagt J, van Moorsel CHM. Borie R, et al. Among authors: prasse a. Eur Respir J. 2023 Mar 16;61(3):2201383. doi: 10.1183/13993003.01383-2022. Print 2023 Mar. Eur Respir J. 2023. PMID: 36549714 Free article. Review.
Airway basal cells show a dedifferentiated KRT17highPhenotype and promote fibrosis in idiopathic pulmonary fibrosis.
Jaeger B, Schupp JC, Plappert L, Terwolbeck O, Artysh N, Kayser G, Engelhard P, Adams TS, Zweigerdt R, Kempf H, Lienenklaus S, Garrels W, Nazarenko I, Jonigk D, Wygrecka M, Klatt D, Schambach A, Kaminski N, Prasse A. Jaeger B, et al. Among authors: prasse a. Nat Commun. 2022 Sep 26;13(1):5637. doi: 10.1038/s41467-022-33193-0. Nat Commun. 2022. PMID: 36163190 Free PMC article.
microRNA-33 deficiency in macrophages enhances autophagy, improves mitochondrial homeostasis, and protects against lung fibrosis.
Ahangari F, Price NL, Malik S, Chioccioli M, Bärnthaler T, Adams TS, Kim J, Pradeep SP, Ding S, Cosmos C Jr, Rose KS, McDonough JE, Aurelien NR, Ibarra G, Omote N, Schupp JC, DeIuliis G, Villalba Nunez JA, Sharma L, Ryu C, Dela Cruz CS, Liu X, Prasse A, Rosas I, Bahal R, Fernández-Hernando C, Kaminski N. Ahangari F, et al. Among authors: prasse a. JCI Insight. 2023 Feb 22;8(4):e158100. doi: 10.1172/jci.insight.158100. JCI Insight. 2023. PMID: 36626225 Free PMC article.
Integrative analysis of cell state changes in lung fibrosis with peripheral protein biomarkers.
Mayr CH, Simon LM, Leuschner G, Ansari M, Schniering J, Geyer PE, Angelidis I, Strunz M, Singh P, Kneidinger N, Reichenberger F, Silbernagel E, Böhm S, Adler H, Lindner M, Maurer B, Hilgendorff A, Prasse A, Behr J, Mann M, Eickelberg O, Theis FJ, Schiller HB. Mayr CH, et al. Among authors: prasse a. EMBO Mol Med. 2021 Apr 9;13(4):e12871. doi: 10.15252/emmm.202012871. Epub 2021 Mar 2. EMBO Mol Med. 2021. PMID: 33650774 Free PMC article.
A Phase IIb Randomized Clinical Study of an Anti-αvβ6 Monoclonal Antibody in Idiopathic Pulmonary Fibrosis.
Raghu G, Mouded M, Chambers DC, Martinez FJ, Richeldi L, Lancaster LH, Hamblin MJ, Gibson KF, Rosas IO, Prasse A, Zhao G, Serenko M, Novikov N, McCurley A, Bansal P, Stebbins C, Arefayene M, Ibebunjo S, Violette SM, Gallagher D, Behr J. Raghu G, et al. Among authors: prasse a. Am J Respir Crit Care Med. 2022 Nov 1;206(9):1128-1139. doi: 10.1164/rccm.202112-2824OC. Am J Respir Crit Care Med. 2022. PMID: 35771569 Clinical Trial.
Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial.
Behr J, Prasse A, Kreuter M, Johow J, Rabe KF, Bonella F, Bonnet R, Grohe C, Held M, Wilkens H, Hammerl P, Koschel D, Blaas S, Wirtz H, Ficker JH, Neumeister W, Schönfeld N, Claussen M, Kneidinger N, Frankenberger M, Hummler S, Kahn N, Tello S, Freise J, Welte T, Neuser P, Günther A; RELIEF investigators. Behr J, et al. Among authors: prasse a. Lancet Respir Med. 2021 May;9(5):476-486. doi: 10.1016/S2213-2600(20)30554-3. Epub 2021 Mar 30. Lancet Respir Med. 2021. PMID: 33798455 Clinical Trial.
[Sarcoidosis].
Prasse A, Müller-Quernheim J. Prasse A, et al. Internist (Berl). 2009 May;50(5):581-90. doi: 10.1007/s00108-009-2382-2. Internist (Berl). 2009. PMID: 19367373 Review. German.
Rebuttal From Dr Prasse.
Prasse A. Prasse A. Chest. 2019 Aug;156(2):208-209. doi: 10.1016/j.chest.2019.03.029. Chest. 2019. PMID: 31395257 No abstract available.
186 results